论文部分内容阅读
目的:比较阿奇霉素与红霉素治疗儿童支原体肺炎的临床疗效及安全性。方法:将2009年1月～2011年8月我院收入的80例患儿随机分为对照组和治疗组,分别给予红霉素与阿奇霉素治疗,记录并作回顾性分析。结果:对2组疗效进行对比分析,二者的差异具有统计学意义(P<0.05),可认为治疗组疗效优于对照组。结论:阿奇霉素对儿童支原体肺炎的治疗效果好,不良反应低且轻,值得临床进一步推广应用。
Objective: To compare the clinical efficacy and safety of azithromycin and erythromycin in children with mycoplasma pneumonia. Methods: From January 2009 to August 2011 80 cases of children hospitalized income were randomly divided into control group and treatment group, were treated with erythromycin and azithromycin, recorded and retrospectively analyzed. Results: The two groups of comparative analysis of efficacy, the difference was statistically significant (P <0.05), the treatment group can be considered better than the control group. Conclusion: Azithromycin has a good curative effect on mycoplasma pneumonia in children with low and mild adverse reactions, which is worthy of further clinical application.